文献速递哮喘慢阻肺

哮喘-慢阻肺重叠综合征的定义:一项基于人群的研究

Defining asthma-COPD overlap syndrome: a population-based study.
PubMed 文献 · Eur Respir J · 2017-05-01

该研究基于荷兰肥胖流行病学研究2008-2012年纳入的5675名45-65岁个体(其中846名哮喘/慢阻肺患者),随访中位1.8年,评估不同ACOS定义对患病率、患者特征和急性加重的影响。结果显示ACOS患病率因定义不同在4.4%至38.3%之间波动,注册定义与自报定义间一致性低,且注册定义下急性加重风险最高(调整IRR 1.6,95%CI 1.2-2.1)。作者呼吁亟需就不同医疗场景下的ACOS定义达成共识。

要点

  • ACOS患病率因定义不同波动于4.4%-38.3%,提示定义选择显著影响流行病学估计。
  • 注册定义与自报定义间一致性低(κ=0.04),加肺功能后仅升至0.41。
  • 注册定义下ACOS患者急性加重风险较哮喘患者升高(调整IRR 1.6,95%CI 1.2-2.1)。

核心结论

  • 不同ACOS定义间一致性低,导致患病率、患者特征和急性加重风险存在差异,亟需就不同医疗场景下的ACOS定义达成共识。

研究设计与样本

  • 基于荷兰肥胖流行病学研究,纳入5675名45-65岁个体(其中846名哮喘/慢阻肺患者),随访中位1.8年。
  • ACOS定义采用近期共识标准及另外五种基于注册、问卷和肺功能的定义。

主要发现

  • 哮喘/慢阻肺人群中ACOS患病率因定义不同在4.4%至38.3%之间波动。
  • 注册定义与自报ACOS间一致性为0.04,加入肺功能(FEV1/FVC<0.7)后为0.41。
  • 注册定义或自报定义下ACOS患者中仅51%和33%存在FEV1/FVC<0.7。
  • 自报ACOS较注册ACOS的哮喘病程更长(平均差22年,95%CI 12-33)。
  • 注册定义ACOS较哮喘的急性加重风险最高(调整IRR 1.6,95%CI 1.2-2.1)。

关键数值与推荐

  • ACOS共识标准及五种替代定义(基于注册、问卷和肺功能)。
  • 肺功能定义使用FEV1/FVC<0.7。

临床怎么用

  • 临床识别ACOS时需注意定义差异对患病率和风险分层的影响。
  • 注册定义下ACOS患者急性加重风险较高,可能需更积极管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) seems an important clinical phenotype, but multiple definitions have been proposed. This study's objectives were to assess the effect of different ACOS definitions on prevalence, patient characteristics and exacerbations.5675 individuals aged 45-65 years, with 846 asthma/COPD patients, were included in the Netherlands Epidemiology of Obesity study between 2008 and 2012, and followed-up for a median of 1.8 years. ACOS was defined by recent consensus criteria and five other definitions, based on registry, questionnaires and lung function.Prevalence of ACOS in the asthma/COPD population ranged between 4.4% and 38.3%, depending on the definition used. Agreement between registry-based and self-reported ACOS was 0.04 and 0.41 when lung function (forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) <0.7) was added. With registry or self-report defined ACOS, only 51% and 33% had FEV1/FVC <0.7. Patient characteristics were similar, but asthma duration was longer with self-reported compared with registry-based ACOS (mean difference 22 years (95% CI 12-33)). Exacerbation risk was highest with registry-based ACOS compared with asthma (adjusted incidence rate ratio 1.6 (95% CI 1.2-2.1)).This study adds important knowledge about agreement between ACOS definitions and their relation with exacerbations. Given the low agreement, differences in prevalence, patient characteristics and risk of exacerbations, consensus about ACOS definition in different care settings is urgently needed.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Bonten TN, Kasteleyn MJ, de Mutsert R, et al. Defining asthma-COPD overlap syndrome: a population-based study. Eur Respir J. 2017. PMID: 28461292. doi:10.1183/13993003.02008-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。